Purchase Order FA523623P3069
- Not listed
- This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
- This is a firm fixed-price purchase order awarded by the U.S. Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of Illumina sequencing platforms, including MiSeq and NextSeq systems, to be used for DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. The award has a ceiling value of $223,391.17 and an ultimate completion date of September 7, 2026. Bio-Active Company...
- This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...
- This firm fixed price purchase order was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide Illumina reagents on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The $27,544.10 contract was issued by the U.S. Department of the Army and has a period of performance ending on September 30, 2024. Bio-Active Company LIMITED has a history of delivering genetic sequencing systems, reagents, and testing materials to...
- This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
- This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the acquisition of MISEQI100PLUS systems on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) Thailand. The contract has a ceiling value of $174,099.88 and an ultimate completion date of November 30, 2025. No small business set-aside was used for this...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $102,468 contract is for preventive maintenance services on an Illumina MiSeq genetic sequencing system operated by the Naval Medical Research Unit 2 (NAMRU-2) laboratory in Cambodia. The contract has a completion date of March 7, 2020 and was awarded on March 3, 2017. No set-aside provisions were...
- This firm fixed-price purchase order, valued at $116,870.00, was awarded to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract requires the vendor to provide medical equipment and reagents to the Armed Forces Research Institute of Medical Sciences (AFRIMS), which is associated with the U.S. Department of the Navy. The contract has an ultimate completion date of October 15, 2025. Bio-Active Company LIMITED is an experienced provider of genetic...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award appears to be part of a larger program for Bio-Active Company LIMITED to provide genetic sequencing services and instrument maintenance to various U.S. government agencies in Thailand, as the company holds a Blanket Purchase Agreement for these services that was awarded in 2021. No set-aside designation was used for this specific purchase order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 3/21/23 |